Saturday, May 10, 2025
  • Business
  • Investing
  • World-news
  • Stock
No Result
View All Result
Finance Mastery News
Advertisement
  • Business
  • Investing
  • World-news
  • Stock
No Result
View All Result
Finance Mastery News
No Result
View All Result
Home Investing

FDA Fast Track Designation for Narmafotinib in Advanced Pancreatic Cancer

admin by admin
September 20, 2024
in Investing
0
FDA Fast Track Designation for Narmafotinib in Advanced Pancreatic Cancer
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Amplia Therapeutics Limited (ASX: ATX), (“Amplia” or the “Company”), is pleased to announce that the United States Food and Drug Administration (FDA) has granted Fast Track Designation to Amplia’s Focal Adhesion Kinase inhibitor, narmafotinib, for the treatment of advanced pancreatic cancer.

HIGHLIGHTS

The US FDA has granted Fast Track Designation to Amplia’s lead drug narmafotinib in advanced pancreatic cancerFast Track Designation facilitates the development of investigational drugs and allows for expedited review

Fast Track Designation is available to drugs that may provide an advantage over current therapies in the treatment of serious conditions. It is designed to speed the development of these drugs to enable patients to receive them sooner. This Designation will grant the Company access to more frequent meetings, and written communication, with the FDA. In future, narmafotinib may be eligible for Accelerated Approval and Priority Review. The Company has previously received Orphan Drug Designation from the FDA for narmafotinib in pancreatic cancer.

The Company’s CEO and Managing Director, Dr Chris Burns, commented, “Fast Track Designation for narmafotinib is a significant milestone for the Company. With this designation, we can work more closely with the FDA to accelerate our clinical program and gather the most compelling evidence for regulatory approval in this devastating disease.”

Amplia’s clinical trial in advanced pancreatic cancer, the ACCENT trial, is ongoing in Australia and South Korea. Earlier this year, the Company announced that the US FDA had cleared its IND1 application for a trial of narmafotinib in pancreatic cancer in the US. This trial is in advanced planning stages.

This ASX announcement was approved and authorised for release by the Board of Amplia Therapeutics.

Click here for the full ASX Release

This post appeared first on investingnews.com

Previous Post

JPMorgan creates new role overseeing junior bankers as Wall Street wrestles with workload concerns

Next Post

How to Invest in Silver (Updated 2024)

admin

admin

Next Post
How to Invest in Silver (Updated 2024)

How to Invest in Silver (Updated 2024)

    Fill Out & Get More Relevant News


    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    • Trending
    • Comments
    • Latest
    Criminals are looting millions from ATMs in Europe. Here’s why Germany is a prime target

    Criminals are looting millions from ATMs in Europe. Here’s why Germany is a prime target

    October 28, 2024
    Israeli MP behind bill to expel key UN agency accuses US of interfering with process

    Israeli MP behind bill to expel key UN agency accuses US of interfering with process

    October 28, 2024
    British nurse Lucy Letby loses bid to appeal single attempted murder conviction

    British nurse Lucy Letby loses bid to appeal single attempted murder conviction

    October 25, 2024
    North Korean troops spotted in Russian border region with Ukraine, says Kyiv

    North Korean troops spotted in Russian border region with Ukraine, says Kyiv

    October 25, 2024
    Putin, Xi and friendly world leaders celebrate Russia’s Victory Day at Moscow Parade

    Putin, Xi and friendly world leaders celebrate Russia’s Victory Day at Moscow Parade

    0
    Private payroll growth slowed to 122,000 in July, less than expected, ADP says

    Private payroll growth slowed to 122,000 in July, less than expected, ADP says

    0
    The 10 worst states to retire in the U.S. No. 1 isn’t California or New York

    The 10 worst states to retire in the U.S. No. 1 isn’t California or New York

    0
    Boeing taps aerospace veteran Ortberg to replace Dave Calhoun as CEO

    Boeing taps aerospace veteran Ortberg to replace Dave Calhoun as CEO

    0
    Putin, Xi and friendly world leaders celebrate Russia’s Victory Day at Moscow Parade

    Putin, Xi and friendly world leaders celebrate Russia’s Victory Day at Moscow Parade

    May 10, 2025
    Ellen Miles is planting seeds of hope through guerrilla gardening

    Ellen Miles is planting seeds of hope through guerrilla gardening

    May 10, 2025
    Sycamore Gap: Two men convicted of felling one of UK’s most famous trees

    Sycamore Gap: Two men convicted of felling one of UK’s most famous trees

    May 10, 2025
    Ukraine says it has uncovered Hungarian spy network working in border region

    Ukraine says it has uncovered Hungarian spy network working in border region

    May 10, 2025

    Recent News

    Putin, Xi and friendly world leaders celebrate Russia’s Victory Day at Moscow Parade

    Putin, Xi and friendly world leaders celebrate Russia’s Victory Day at Moscow Parade

    May 10, 2025
    Ellen Miles is planting seeds of hope through guerrilla gardening

    Ellen Miles is planting seeds of hope through guerrilla gardening

    May 10, 2025
    Sycamore Gap: Two men convicted of felling one of UK’s most famous trees

    Sycamore Gap: Two men convicted of felling one of UK’s most famous trees

    May 10, 2025
    Ukraine says it has uncovered Hungarian spy network working in border region

    Ukraine says it has uncovered Hungarian spy network working in border region

    May 10, 2025

    Disclaimer: financemasterynews.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Browse by Category

    • Business
    • Investing
    • Stock
    • World-news

    Recent News

    Putin, Xi and friendly world leaders celebrate Russia’s Victory Day at Moscow Parade

    Putin, Xi and friendly world leaders celebrate Russia’s Victory Day at Moscow Parade

    May 10, 2025
    Ellen Miles is planting seeds of hope through guerrilla gardening

    Ellen Miles is planting seeds of hope through guerrilla gardening

    May 10, 2025
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 financemasterynews.com | All Rights Reserved

    No Result
    View All Result

    Copyright © 2025 financemasterynews.com | All Rights Reserved